| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.55B | 22.59B | 21.27B | 19.47B | 16.91B | 17.17B |
| Gross Profit | 9.65B | 9.88B | 9.86B | 8.12B | 6.65B | 7.16B |
| EBITDA | 3.49B | 4.22B | 4.48B | 3.65B | 3.44B | 2.32B |
| Net Income | 2.04B | 2.11B | 2.23B | 2.21B | 2.14B | 1.14B |
Balance Sheet | ||||||
| Total Assets | 68.30B | 69.82B | 66.61B | 53.00B | 50.68B | 51.65B |
| Cash, Cash Equivalents and Short-Term Investments | 7.58B | 9.01B | 11.91B | 14.37B | 16.41B | 17.11B |
| Total Debt | 5.28B | 5.59B | 6.24B | 3.92B | 3.09B | 4.69B |
| Total Liabilities | 17.73B | 18.64B | 18.88B | 12.84B | 11.01B | 13.31B |
| Stockholders Equity | 50.22B | 50.83B | 47.39B | 39.83B | 39.36B | 37.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -150.00M | -2.05B | 2.64B | 2.36B | 2.39B |
| Operating Cash Flow | 0.00 | 1.11B | 3.20B | 2.77B | 2.39B | 2.50B |
| Investing Cash Flow | 0.00 | -817.00M | -5.93B | -1.52B | -457.00M | 1.13B |
| Financing Cash Flow | 0.00 | -3.10B | -421.00M | -3.38B | -2.72B | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥41.52B | 10.95 | ― | 3.62% | -0.98% | -29.86% | |
72 Outperform | ¥70.61B | 3.05 | ― | 2.73% | 10.48% | -34.38% | |
71 Outperform | ¥34.09B | 3.77 | ― | 5.84% | -2.38% | -77.89% | |
70 Outperform | ¥262.97B | 19.60 | ― | 1.46% | 12.02% | -15.70% | |
68 Neutral | ¥746.94B | 16.45 | 8.48% | 2.02% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | ¥26.94B | 13.91 | ― | 4.99% | -7.21% | -5127.88% |